If approved , cagrilintide could become a first-line option in pharmacologic obesity management , especially within aesthetic settings where facial fullness, contouring, and body composition improvements are key patient goals
Heres a closer look: Tirzepatide Tizepatide is the first in its class of drugs
While many people who take GLP-1 medications for weight loss experience tremendous benefits from the drugs, the drugs may have other uses
Strengths of STEP 5 include the high rates of adherence to treatment and completion of the trial (which contributed to consistency in findings between the two estimands)
If and when it becomes available and the data supports it, we will discuss it during visits
7 Side effects The adverse events reported in the clinical trials of tirzepatide are very similar to those seen in trials of GLP-1 receptor agonists and mainly involve the gastrointestinal system